Cerenome
CNSY
11 hedge funds and large institutions have $875K invested in Cerenome in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
120% more funds holding
Funds holding: 5 → 11 (+6)
59% more capital invested
Capital invested by funds: $552K → $875K (+$323K)
1.68% more ownership
Funds ownership: 6.34% → 8.01% (+1.7%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$168K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$58.2K |
| 3 |
VF
Virtu Financial
New York
|
+$56.2K |
| 4 |
Two Sigma Investments
New York
|
+$42.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$127K |
CNSY Hedge Fund Activity: Q3 2020 in Review
11 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q3 2020, worth a combined $875K — up 59% from $552K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CNSY positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $168K. The largest seller was Renaissance Technologies, cutting an estimated $127K.
- 11 institutional investors held Cerenome (CNSY) as of Q3 2020, up from 5 in Q2 2020.
- Funds reported $875K of Cerenome stock for Q3 2020, up 59% quarter-over-quarter.
- 6 funds opened new Cerenome positions in Q3 2020 and 0 closed out, a net change of +6 holders.
- The largest Cerenome buyer in Q3 2020 was Goldman Sachs, an estimated $168K added.
- The largest Cerenome seller in Q3 2020 was Renaissance Technologies, an estimated $127K sold.
Based on aggregated 13F filings for Q3 2020.